↓ Skip to main content

Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial

Overview of attention for article published in Frontiers in immunology, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
1 news outlet
twitter
10 X users

Readers on

mendeley
95 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and Safety of BCG Revaccination With M. bovis BCG Moscow to Prevent COVID-19 Infection in Health Care Workers: A Randomized Phase II Clinical Trial
Published in
Frontiers in immunology, March 2022
DOI 10.3389/fimmu.2022.841868
Pubmed ID
Authors

Laura Raniere Borges dos Anjos, Adeliane Castro da Costa, Amanda da Rocha Oliveira Cardoso, Rafael Alves Guimarães, Roberta Luiza Rodrigues, Kaio Mota Ribeiro, Kellen Christina Malheiros Borges, Ana Carolina de Oliveira Carvalho, Carla Iré Schnier Dias, Aline de Oliveira Rezende, Carine de Castro Souza, Renato Rodney Mota Ferreira, Guylherme Saraiva, Lilia Cristina de Souza Barbosa, Tayro da Silva Vieira, Marcus Barreto Conte, Marcelo Fouad Rabahi, André Kipnis, Ana Paula Junqueira-Kipnis

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 95 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 14%
Student > Master 6 6%
Professor > Associate Professor 4 4%
Student > Ph. D. Student 4 4%
Student > Doctoral Student 3 3%
Other 14 15%
Unknown 51 54%
Readers by discipline Count As %
Medicine and Dentistry 16 17%
Nursing and Health Professions 9 9%
Biochemistry, Genetics and Molecular Biology 3 3%
Agricultural and Biological Sciences 3 3%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 8 8%
Unknown 54 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2022.
All research outputs
#2,315,198
of 26,556,052 outputs
Outputs from Frontiers in immunology
#2,314
of 33,375 outputs
Outputs of similar age
#52,802
of 454,422 outputs
Outputs of similar age from Frontiers in immunology
#103
of 1,658 outputs
Altmetric has tracked 26,556,052 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,375 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,422 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 1,658 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.